Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy.
Autism
Children
Cost-effectiveness
Epilepsy
Family impacts
Healthcare expenditure
Journal
Journal of autism and developmental disorders
ISSN: 1573-3432
Titre abrégé: J Autism Dev Disord
Pays: United States
ID NLM: 7904301
Informations de publication
Date de publication:
04 May 2023
04 May 2023
Historique:
accepted:
17
02
2023
medline:
5
5
2023
pubmed:
5
5
2023
entrez:
4
5
2023
Statut:
aheadofprint
Résumé
We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure.
Identifiants
pubmed: 37142904
doi: 10.1007/s10803-023-05941-8
pii: 10.1007/s10803-023-05941-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Commission européenne Office Européen de Lutte Antifraude
ID : n/a
Informations de copyright
© 2023. The Author(s).
Références
Allers, K., Essue, B. M., Hackett, M. L., Muhunthan, J., Anderson, C. S., Pickles, K., Scheibe, F., & Jan, S. (2015). The economic impact of epilepsy: a systematic review. BMC neurology, 15, 245. https://doi.org/10.1186/s12883-015-0494-y
doi: 10.1186/s12883-015-0494-y
pubmed: 26607561
pmcid: 4660784
Almathami, H., Win, K. T., & Vlahu-Gjorgievska, E. (2020). Barriers and facilitators that influence Telemedicine-Based, Real-Time, Online Consultation at Patients’ Homes: systematic literature review. Journal of medical Internet research, 22(2), e16407. https://doi.org/10.2196/16407
doi: 10.2196/16407
pubmed: 32130131
pmcid: 7059083
Andronis, L., Barton, P., & Bryan, S. (2009). Sensitivity analysis in economic evaluation: an audit of NICE current practice and a review of its use and value in decision-making. Health technology assessment (Winchester England), 13(29), iii–61. https://doi.org/10.3310/hta13290
doi: 10.3310/hta13290
pubmed: 19500484
Argumosa, A., & Herranz, J. L. (2004). Childhood epilepsy: a critical review of cost-of-illness studies. Epileptic disorders: international epilepsy journal with videotape, 6(1), 31–40.
pubmed: 15075066
Autistica (2022). Make the most of a telephone health appointment. Retrieved October 15 h 2021 from https://www.autistica.org.uk/what-is-autism/coronavirus/make-the-most-of-a-telephone-appointment
Barrett, B., Byford, S., Sharac, J., Hudry, K., Leadbitter, K., Temple, K., Aldred, C., Slonims, V., Green, J., & PACT Consortium. (2012). Service and wider societal costs of very young children with autism in the UK. Journal of autism and developmental disorders, 42(5), 797–804. https://doi.org/10.1007/s10803-011-1306-x
doi: 10.1007/s10803-011-1306-x
pubmed: 22089166
Besag, F. M. (2017). Epilepsy in patients with autism: Links, risks and treatment challenges. Neuropsychiatric Disease and Treatment, 14, 1–10. https://doi.org/10.2147/NDT.S120509
Buescher, A. V., Cidav, Z., Knapp, M., & Mandell, D. S. (2014). Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA pediatrics, 168(8), 721–728. https://doi.org/10.1001/jamapediatrics.2014.210
doi: 10.1001/jamapediatrics.2014.210
pubmed: 24911948
Curtis, L., & Burns, A. (2015). Unit costs of health and social care. Canterbury: Personal Social Services Research Unit. Retrieved October 15 h 2021, from https://www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2015/
Dillenburger, K., Jordan, J. A., McKerr, L., & Keenan, M. (2015). The Millennium child with autism: early childhood trajectories for health, education and economic wellbeing. Developmental neurorehabilitation, 18(1), 37–46. https://doi.org/10.3109/17518423.2014.964378
doi: 10.3109/17518423.2014.964378
pubmed: 25289682
Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2005). Methods for the economic evaluation of Health Care Programmes. Oxford: Oxford University Press.
El Achkar, C. M., & Spence, S. J. (2015). Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Epilepsy & behavior: E&B, 47, 183–190. https://doi.org/10.1016/j.yebeh.2014.12.022
doi: 10.1016/j.yebeh.2014.12.022
Fleming, M., Fitton, C. A., Steiner, M. F. C., McLay, J. S., Clark, D., King, A., Mackay, D. F., & Pell, J. P. (2019). Educational and health outcomes of children and adolescents receiving antiepileptic medication: Scotland-wide record linkage study of 766 244 schoolchildren. BMC Public Health, 19(1), 595. https://doi.org/10.1186/s12889-019-6888-9
Frew, E. J., Sandercock, J., Whitehouse, W. P., & Bryan, S. (2007). The cost-effectiveness of newer drugs as add-on therapy for children with focal epilepsies. Seizure, 16(2), 99–112. https://doi.org/10.1016/j.seizure.2006.10.017
doi: 10.1016/j.seizure.2006.10.017
pubmed: 17161630
Hawkins, N., Epstein, D., Drummond, M., Wilby, J., Kainth, A., Chadwick, D., & Sculpher, M. (2005). Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Medical decision making: an international journal of the Society for Medical Decision Making, 25(5), 493–510. https://doi.org/10.1177/0272989X05280559
doi: 10.1177/0272989X05280559
pubmed: 16160206
Health Information and Quality Authority (HIQA). Guidelines for the economic evaluation of health technologies in Ireland 2020. https://www.hiqa.ie/reports-and-publications/health-technology-assessment/guidelines-economic-evaluation-health
Health Services Executive (HSE). (2021). Hospital charges. Retrieved October 15, 2021, from https://www.hse.ie/eng/about/who/acute-hospitals-division/patient-care/hospital-charges/
Hirfanoglu, T., Serdaroglu, A., Cansu, A., Soysal, A. S., Derle, E., & Gucuyener, K. (2009). Do knowledge of, perception of, and attitudes toward epilepsy affect the quality of life of Turkish children with epilepsy and their parents? Epilepsy & Behavior: E&B, 14(1), 71–77. https://doi.org/10.1016/j.yebeh.2008.08.011
Hirvikoski, T., Mittendorfer-Rutz, E., Boman, M., Larsson, H., Lichtenstein, P., & Bölte, S. (2016). Premature mortality in autism spectrum disorder. The British journal of psychiatry: the journal of mental science, 208(3), 232–238. https://doi.org/10.1192/bjp.bp.114.160192 .
doi: 10.1192/bjp.bp.114.160192
pubmed: 26541693
Hunter, R. M., Reilly, C., Atkinson, P., Das, K. B., Gillberg, C., Chin, R. F., Scott, R. C., Neville, B. G., & Morris, S. (2015). The health, education, and social care costs of school-aged children with active epilepsy: a population-based study. Epilepsia, 56(7), 1056–1064. https://doi.org/10.1111/epi.13015
doi: 10.1111/epi.13015
pubmed: 26040629
Hussain, S. A., Ortendahl, J. D., Bentley, T., Harmon, A. L., Gupta, S., Begley, C. E., Khilfeh, I., & Knoth, R. L. (2020). The economic burden of caregiving in epilepsy: an estimate based on a survey of US caregivers. Epilepsia, 61(2), 319–329. https://doi.org/10.1111/epi.16429
doi: 10.1111/epi.16429
pubmed: 31953846
Jacoby, A., & Austin, J. K. (2007). Social stigma for adults and children with epilepsy. Epilepsia, 48(Suppl 9), 6–9. https://doi.org/10.1111/j.1528-1167.2007.01391.x
Järbrink, K., McCrone, P., Fombonne, E., Zandén, H., & Knapp, M. (2000) Cost-impact of young adults with high-functioning autistic spectrum disorder. Research in Developmental Disabilities 28(1), 94–104.
Jennum, P., Gyllenborg, J., & Kjellberg, J. (2011). The social and economic consequences of epilepsy: a controlled national study. Epilepsia, 52(5), 949–956. https://doi.org/10.1111/j.1528-1167.2010.02946.x
doi: 10.1111/j.1528-1167.2010.02946.x
pubmed: 21275976
Jennum, P., Pickering, L., Christensen, J., Ibsen, R., & Kjellberg, J. (2016). Welfare cost of childhood- and adolescent-onset epilepsy: a controlled national study. Epilepsy & behavior: E&B, 61, 72–77. https://doi.org/10.1016/j.yebeh.2016.04.044
doi: 10.1016/j.yebeh.2016.04.044
Jennum, P., Christensen, J., Ibsen, R., & Kjellberg, J. (2016). Long-term socioeconomic consequences and health care costs of childhood and adolescent-onset epilepsy. Epilepsia, 57(7), 1078–1085. https://doi.org/10.1111/epi.13421 .
doi: 10.1111/epi.13421
pubmed: 27321903
Knapp, M., Snell, T., Healey, A., Guglani, S., Evans-Lacko, S., Fernandez, J. L., Meltzer, H., & Ford, T. (2015). How do child and adolescent mental health problems influence public sector costs? Interindividual variations in a nationally representative British sample. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 56(6), 667–676. https://doi.org/10.1111/jcpp.12327
Lavelle, T. A., D’Cruz, B. N., Mohit, B., Ungar, W. J., Prosser, L. A., Tsiplova, K., Vera-Llonch, M., & Lin, P. J. (2019). Family Spillover Effects in Pediatric cost-utility analyses. Applied health economics and health policy, 17(2), 163–174. https://doi.org/10.1007/s40258-018-0436-0
doi: 10.1007/s40258-018-0436-0
pubmed: 30350218
Lee, D., Gladwell, D., Batty, A. J., Brereton, N., & Tate, E. (2013). The cost effectiveness of licensed oromucosal midazolam (Buccolam(®)) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited. Paediatric drugs, 15(2), 151–162. https://doi.org/10.1007/s40272-013-0009-5
doi: 10.1007/s40272-013-0009-5
pubmed: 23512129
Lee, D. C., Gladwell, D., Hatswell, A. J., Porter, J., Brereton, N., Tate, E., & Saunders, A. L. (2014). A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe. Health economics review, 4, 6. https://doi.org/10.1186/s13561-014-0006-6
doi: 10.1186/s13561-014-0006-6
pubmed: 24949280
pmcid: 4052771
Liu, X., Sun, X., Sun, C., Zou, M., Chen, Y., Huang, J., Wu, L., & Chen, W. X. (2022). Prevalence of epilepsy in autism spectrum disorders: a systematic review and meta-analysis. Autism, 26(1), 33–50.
doi: 10.1177/13623613211045029
pubmed: 34510916
MIMS Ireland (2019). MPI Media Ltd., Dublin, Ireland. Retrieved October 15 h 2021 from https://www.mims.ie/
National Clinical Guideline Centre (UK). (2012). The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care. Royal College of Physicians (UK).
NICE (2021). Epilepsies: diagnosis and management. Retrieved October 15 h 2021 from https://www.nice.org.uk/guidance/cg137
NICE (2023). Glossary. https://www.nice.org.uk/glossary
Perucca, E., Battino, D., & Tomson, T. (2014). Gender issues in antiepileptic drug treatment. Neurobiology of disease 72 Pt B, 217–223. https://doi.org/10.1016/j.nbd.2014.05.011
Samba Reddy, D. (2017). Sex differences in the anticonvulsant activity of neurosteroids. Journal of neuroscience research, 95(1–2), 661–670. https://doi.org/10.1002/jnr.23853
Snell, T., Knapp, M., Healey, A., Guglani, S., Evans-Lacko, S., Fernandez, J. L., Meltzer, H., & Ford, T. (2013). Economic impact of childhood psychiatric disorder on public sector services in Britain: estimates from national survey data. Journal of child psychology and psychiatry, and allied disciplines, 54(9), 977–985. https://doi.org/10.1111/jcpp.12055
Whitehead, S. J., & Ali, S. (2010). Health outcomes in economic evaluation: the QALY and utilities. British medical bulletin, 96, 5–21.
doi: 10.1093/bmb/ldq033
pubmed: 21037243
Widjaja, E., Guttmann, A., Tomlinson, G., Snead, O. C. 3rd, & Sander, B. (2021). Economic burden of epilepsy in children: a population-based matched cohort study in Canada. Epilepsia, 62(1), 152–162. https://doi.org/10.1111/epi.16775
Wijnen, B., van Mastrigt, G., Evers, S., Gershuni, O., Lambrechts, D., Majoie, M., Postulart, D., Aldenkamp, B., & de Kinderen, R. (2017). A systematic review of economic evaluations of treatments for patients with epilepsy. Epilepsia, 58(5), 706–726. https://doi.org/10.1111/epi.13655
doi: 10.1111/epi.13655
pubmed: 28098939
Zack, M. M., & Kobau, R. (2017). National and state estimates of the numbers of adults and children with active epilepsy - United States, 2015. MMWR. Morbidity and Mortality Weekly Report, 66(31), 821–825. https://doi.org/10.15585/mmwr.mm6631a1